Targacept: Annual Report 2012 (Targacept) - Mar 22, 2013 - Anticipated patent expiry of composition of matter for a racemic mixture that includes TC-5619 in March 2019; Anticipated patent expiry of composition of matter for a family of racemic compounds that includes a racemic mixture that includes TC-5619 in August 2019; Anticipated patent expiry of composition of matter for a sub-family of racemic compounds that includes a racemic mixture that includes TC-5619 in Dec 2018; Anticipated patent expiry of composition of matter for salt forms, including the preferred salt in January 2029; Anticipated patent expiry of method of use of a racemix mixture that includes TC-5619 for schizophrenia in Feb 2023; Anticipated patent expiry of method of use of racemic mixture that includes TC-5619 for schizophrenia in Nov 2025; Anticipated patent expiry of commercial method and composition of matter for synthetic intermediates for manufacture of TC-5619 in Aug 2028
Anticipated patent expiry • Schizophrenia
|